Chief Operating Officer
Eric Loumeau joined AnaptysBio in August 2018 with more than twenty years of experience in biotech. Mr. Loumeau’s expertise includes corporate finance, raising over $5 billion in over 75 public and private securities offerings, and mergers and acquisitions. Mr. Loumeau previously served as General Counsel and Chief Compliance Officer of Otonomy, Inc. Before joining Otonomy, Mr. Loumeau served as Chief Financial Officer of Rempex Pharmaceuticals, Inc., and continued as Vice President of Legal Affairs following Rempex’s acquisition by The Medicines Company. He also previously functioned as General Counsel at Hollis-Eden Pharmaceuticals, Inc. Mr. Loumeau’s experience as outside corporate counsel at national law firms includes tenures at Skadden, Arps, Slate, Meagher & Flom LLP, Cooley LLP, Mintz Levin Cohn Ferris Glovsky and Popeo PC, and Bass, Berry & Sims PLC. Mr. Loumeau received his J.D. from Boalt Hall School of Law at the University of California, Berkeley, and his B.S. in Finance from Brigham Young University.